American International Group, Inc. Catalyst Pharmaceuticals, Inc. Transaction History

American International Group, Inc.

$8.86 Billion
Q2 2024

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 13, 2024	BUY	$13.18 - $17.11 $72,002 - $93,471	5,463 Added 10.0%	60,087 $957,000
Q4 2023 Feb 13, 2024	SELL	$11.78 - $17.29 $5,383 - $7,901	-457 Reduced 0.83%	54,624 $918,000
Q3 2023 Nov 13, 2023	BUY	$11.69 - $15.02 $37,980 - $48,799	3,249 Added 6.27%	55,081 $643,000
Q2 2023 Aug 04, 2023	SELL	$11.5 - $18.08 $12,098 - $19,020	-1,052 Reduced 1.99%	51,832 $696,000
Q1 2023 May 12, 2023	BUY	$14.34 - $21.05 $3,513 - $5,157	245 Added 0.47%	52,884 $876,000
Q4 2022 Feb 10, 2023	BUY	$12.25 - $19.5 $3,001 - $4,777	245 Added 0.47%	52,639 $979,000
Q3 2022 Nov 14, 2022	BUY	$7.06 - $15.52 $53,288 - $117,144	7,548 Added 16.83%	52,394 $672,000
Q2 2022 Aug 12, 2022	SELL	$6.23 - $8.57 $20,945 - $28,812	-3,362 Reduced 6.97%	44,846 $314,000
Q1 2022 May 13, 2022	SELL	$5.31 - $8.31 $18,022 - $28,204	-3,394 Reduced 6.58%	48,208 $400,000
Q4 2021 Feb 11, 2022	SELL	$5.21 - $7.45 $8,039 - $11,495	-1,543 Reduced 2.9%	51,602 $349,000
Q3 2021 Nov 12, 2021	SELL	$4.85 - $6.04 $6,130 - $7,634	-1,264 Reduced 2.32%	53,145 $282,000
Q2 2021 Aug 13, 2021	SELL	$4.29 - $6.05 $9,270 - $13,074	-2,161 Reduced 3.82%	54,409 $313,000
Q1 2021 May 07, 2021	BUY	$3.45 - $4.69 $517 - $703	150 Added 0.27%	56,570 $261,000
Q4 2020 Feb 12, 2021	SELL	$2.97 - $3.83 $4,808 - $6,200	-1,619 Reduced 2.79%	56,420 $188,000
Q3 2020 Nov 04, 2020	SELL	$2.97 - $5.08 $3,917 - $6,700	-1,319 Reduced 2.22%	58,039 $172,000
Q2 2020 Aug 12, 2020	BUY	$3.48 - $5.05 $7,840 - $11,377	2,253 Added 3.95%	59,358 $274,000
Q1 2020 May 04, 2020	SELL	$2.61 - $5.21 $8,613 - $17,193	-3,300 Reduced 5.46%	57,105 $220,000
Q4 2019 Feb 05, 2020	SELL	$3.67 - $5.7 $1,860 - $2,889	-507 Reduced 0.83%	60,405 $227,000
Q3 2019 Nov 08, 2019	SELL	$3.89 - $7.43 $1,653 - $3,157	-425 Reduced 0.69%	60,912 $323,000
Q2 2019 Aug 13, 2019	SELL	$2.7 - $6.11 $464 - $1,050	-172 Reduced 0.28%	61,337 $236,000
Q1 2019 May 06, 2019	SELL	$2.11 - $5.33 $4,207 - $10,628	-1,994 Reduced 3.14%	61,509 $314,000
Q4 2018 Feb 13, 2019	SELL	$1.92 - $3.62 $936 - $1,766	-488 Reduced 0.76%	63,503 $122,000
Q3 2018 Nov 09, 2018	BUY	$2.81 - $3.78 $3,239 - $4,358	1,153 Added 1.83%	63,991 $242,000
Q2 2018 Aug 08, 2018	BUY	$2.26 - $3.84 $15,600 - $26,507	6,903 Added 12.34%	62,838 $196,000
Q1 2018 May 07, 2018	BUY	$2.39 - $4.01 $18,503 - $31,045	7,742 Added 16.06%	55,935 $134,000
Q4 2017 Feb 09, 2018	BUY	$2.51 - $4.4 $572 - $1,003	228 Added 0.48%	48,193 $188,000
Q3 2017 Nov 09, 2017	BUY	$2.4 - $2.94 $115,116 - $141,017	47,965	47,965 $121,000

Others Institutions Holding CPRX

# of Institutions

285

Shares Held

96.6M

Call Options Held

29.2K

Put Options Held

20.5K

Black Rock Inc. New York, NY

18.7M
Shares

$366 Million
0.01% of portfolio
Deerfield Management Company, L.P. (Series C) New York, NY

9.13M
Shares

$179 Million
2.97% of portfolio
Vanguard Group Inc Valley Forge, PA

8.1M
Shares

$158 Million
0.0% of portfolio
State Street Corp Boston, MA

6.03M
Shares

$118 Million
0.0% of portfolio
Dimensional Fund Advisors LP Austin, TX

3M
Shares

$58.7 Million
0.01% of portfolio

View Full List

About CATALYST PHARMACEUTICALS, INC.

Ticker CPRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 102,820,000
Market Cap $2.01B
Description
Catalyst Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on developing and commercializing therapies for people with rare debilitating, chronic neuromuscular, and neurological diseases in the United States. It offers Firdapse, an amifampridine phosphate tablets for the treatment of patients with lambert-eaton myasthe...

More about CPRX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of American International Group, Inc., based on Form 13F filings with the SEC.

News

Stay updated on American International Group, Inc. with notifications on news.

Account